Gene
|
OMIM Diseases
|
Inheritance*
|
% Gene Coverage (20x)
|
HGMD**
|
AARS1
|
Charcot-Marie-Tooth Disease, Epileptic Encephalopathy
|
AD,AR
|
99.07
|
30 of 30
|
ABAT
|
Gaba-Transaminase Deficiency
|
AR
|
100
|
9 of 9
|
ABCA2
|
Intellectual Developmental Disorder, Seizures, Ataxia
|
AR
|
99.05
|
11 of 11
|
ABCC8
|
Diabetes Mellitus, Hyperinsulinemic Hypoglycemia, Dend Syndrome
|
AD,AR
|
99.98
|
710 of 712
|
ABCD1
|
Adrenoleukodystrophy
|
X,XR,G
|
100
|
–
|
ACTL6B
|
Epileptic Encephalopathy, Intellectual Developmental Disorder
|
AD,AR
|
100
|
21 of 21
|
ACY1
|
Aminoacylase 1 Deficiency
|
AR
|
100
|
15 of 15
|
ADAM22
|
Epileptic Encephalopathy
|
AR
|
99.98
|
4 of 4
|
ADAR
|
Aicardi-GoutieresSyndrome, DyschromatosisSymmetrica, Bilateral Striatal Necrosis
|
AD,AR
|
99.93
|
252 of 252
|
ADGRG1
|
Polymicrogyria
|
AR
|
100
|
–
|
ADGRV1
|
Febrile Convulsions, Usher Syndrome, Epilepsy
|
AD,AR
|
97.53
|
–
|
ADPRS
|
Neurodegeneration, Ataxia
|
AR
|
99.86
|
11 of 11
|
ADRA2B
|
Epilepsy
|
–
|
100
|
5 of 5
|
ADSL
|
Adenylosuccinate LyaseDeficiency
|
AR
|
100
|
59 of 59
|
AFG3L2
|
OpticAtrophy, Ataxia, Epilepsy
|
AD,AR
|
99.74
|
42 of 42
|
AGA
|
Aspartylglucosaminuria
|
AR
|
100
|
35 of 35
|
AHI1
|
Joubert Syndrome, Retinitis Pigmentosa
|
AR
|
96.79
|
85 of 97
|
AIFM1
|
Oxidative Phosphorylation Deficiency, Cowchock Syndrome, Deafness, Spondyloepimetaphyseal Dysplasia, Leukoencephalopathy, Mitochondrial Encephalomyopathy, Charcot-Marie-Tooth Disease
|
X,XR,G
|
100
|
–
|
AIMP1
|
Leukodystrophy, IntellectualDisability
|
AR
|
100
|
10 of 10
|
AKT3
|
Megalencephaly- Polymicrogyria- Postaxial Polydactyly- Hydrocephalus Syndrome
|
AD
|
99.9
|
9 of 11
|
ALDH3A2
|
Sjogren-Larsson Syndrome
|
AR
|
96
|
119 of 119
|
ALDH4A1
|
Hyperprolinemia
|
AR
|
100
|
7 of 7
|
ALDH5A1
|
SuccinicSemialdehyde Dehydrogenase Deficiency
|
AR
|
95.41
|
65 of 69
|
ALDH7A1
|
Epilepsy
|
AR
|
99.98
|
131 of 134
|
ALG1
|
CongenitalDisorder Of Glycosylation
|
AR
|
100
|
46 of 46
|
ALG12
|
CongenitalDisorder Of Glycosylation
|
AR
|
100
|
17 of 17
|
ALG13
|
EpilepticEncephalopathy, IntellectualDisability
|
X,XR,XD,G
|
99.62
|
–
|
ALG2
|
Congenital Disorder Of Glycosylation, Myasthenic Syndrome
|
AR
|
99.61
|
7 of 7
|
ALG3
|
CongenitalDisorder Of Glycosylation
|
AR
|
99.2
|
25 of 25
|
ALG6
|
CongenitalDisorder Of Glycosylation
|
AR
|
99.91
|
24 of 24
|
ALG8
|
Congenital Disorder Of Glycosylation, Polycystic Liver Disease
|
AD,AR
|
99.5
|
22 of 22
|
ALG9
|
Congenital Disorder Of Glycosylation, Polycystic Kidney Disease, Microbrachycephaly, Hypertelorism
|
AR
|
99.99
|
6 of 6
|
ALKBH8
|
IntellectualDevelopmental Disorder
|
AR
|
99.2
|
2 of 2
|
AMACR
|
Alpha-Methylacyl-Coa Racemase Deficiency
|
AR
|
100
|
8 of 8
|
AMT
|
GlycineEncephalopathy
|
AR
|
99.98
|
94 of 96
|
ANK3
|
Mental Retardation
|
AR
|
99.76
|
22 of 23
|
ANKRD11
|
Kbg Syndrome, 16q24.3 Microdeletion Syndrome
|
AD
|
99.6
|
119 of 124
|
AP2M1
|
Intellectual Developmental Disorder, Myoclonic Astastic Epilepsy
|
AD
|
100
|
1 of 1
|
AP3B2
|
EpilepticEncephalopathy
|
AR
|
99.95
|
11 of 12
|
AP4B1
|
SpasticParaplegia, IntellectualDisability
|
AR
|
99.64
|
22 of 22
|
AP4E1
|
Spastic Paraplegia, Stuttering, Severe Intellectual Disability
|
AD,AR
|
99.94
|
17 of 17
|
AP4M1
|
Spastic Paraplegia, Severe Intellectual Disability
|
AR
|
100
|
18 of 18
|
AP4S1
|
Spastic Paraplegia, Severe Intellectual Disability
|
AR
|
99.95
|
8 of 8
|
ARFGEF2
|
Microcephaly, Periventricular Nodular Heterotopia
|
AR
|
100
|
15 of 15
|
ARG1
|
Argininemia
|
AR
|
100
|
66 of 68
|
ARHGEF15
|
Angelman Syndrome, Epileptic Encephalopathy, Spastic Ataxia
|
–
|
99.89
|
3 of 3
|
ARHGEF9
|
Hyperekplexia, Epilepsy
|
X,XR,G
|
100
|
–
|
ARID1B
|
Coffin-Siris Syndrome, 6q25 Microdeletion Syndrome
|
AD
|
93.87
|
226 of 238
|
ARL13B
|
Joubert Syndrome
|
AR
|
99.77
|
10 of 10
|
ARSA
|
Metachromatic Leukodystrophy
|
AR
|
98
|
266 of 266
|
ARSB
|
Mucopolysaccharidosis
|
AR
|
99.83
|
217 of 220
|
ARV1
|
EpilepticEncephalopathy
|
AR
|
100
|
3 of 3
|
ARX
|
Corpus Callosum, Epileptic Encephalopathy, Lissencephaly, Mental Retardation, Partington Syndrome, West Syndrome
|
X,XR,G
|
81.92
|
–
|
ASAH1
|
Farber Lipogranulomatosis, Spinal Muscular Atrophy, MyoclonicEpilepsy
|
AR
|
99.98
|
69 of 70
|
ASNS
|
AsparagineSynthetase Deficiency
|
AR
|
99.98
|
37 of 37
|
ASPA
|
CanavanDisease
|
AR
|
99.56
|
93 of 94
|
ASPM
|
Microcephaly
|
AR
|
99.74
|
221 of 222
|
ASXL3
|
Bainbridge-Ropers Syndrome, Feeding Difficulties, Failure To Thrive, Microcephaly
|
AD
|
|
77 of 81
|
ATAD1
|
Hyperekplexia
|
AR
|
99.97
|
3 of 3
|
ATIC
|
Imp Cyclohydrolase, Charcot Marie Tooth Disease
|
AR
|
98.77
|
8 of 8
|
ATN1
|
CongenitalHypotonia, Chorea, Seizures, Dementia, Dentatorubral Pallidoluysian Atrophy
|
AD
|
99.86
|
11 of 11
|
ATP13A2
|
Kufor-Rakeb Syndrome, Spastic Paraplegia, Ceroid Lipofuscinosis
|
AR
|
99.97
|
53 of 53
|
ATP1A2
|
Alternating Hemiplegia Of Childhood, Migraine
|
AD
|
100
|
108 of 108
|
ATP1A3
|
Alternating Hemiplegia Of Childhood, Cerebellar Ataxia, Optic Atrophy, Sensorineuralhearing Loss, Dystonia, Areflexia, Pes Cavus, Parkinsonism
|
AD
|
99.94
|
138 of 138
|
ATP2A2
|
AcrokeratosisVerruciformis, Darier-White Disease
|
AD
|
100
|
298 of 301
|
ATP6AP2
|
Congenital Disorder Of Glycosylation, Mental Retardation, Epilepsy, Parkinsonism
|
X,XR,G
|
100
|
–
|
ATP6V0A2
|
Cutis Laxa, Wrinkly Skin Syndrome
|
AR
|
99.99
|
55 of 55
|
ATP6V1A
|
Cutis Laxa, Epileptic Encephalopathy
|
AD,AR
|
99.98
|
9 of 9
|
ATP7A
|
Cutis Laxa, Menkes Disease, Spinal Muscular Atrophy, Occipital HornSyndrome
|
X,XR,G
|
99.83
|
–
|
ATPAF2
|
AtpaseDeficiency
|
AR
|
100
|
2 of 2
|
ATRX
|
Alpha-Thalassemia MyelodysplasiaSyndrome, Mental Retardation- Hypotonic Facies Syndrome , Carpenter-Waziri Syndrome, Chudley-Lowry-Hoar Syndrome, Holmes- GangSyndrome, Juberg- MarsidiSyndrome, Smith- Fineman-Myers Syndrome
|
X,XR,XD,G
|
98.5
|
–
|
AUH
|
3-Methylglutaconic Aciduria
|
AR
|
99.99
|
11 of 11
|
B4GALT1
|
CongenitalDisorder Of Glycosylation
|
AR
|
99.97
|
3 of 3
|
BCKDK
|
Branched-Chain Ketoacid Dehydrogenase Kinase Deficiency
|
–
|
99.91
|
6 of 6
|
BCS1L
|
BjornstadSyndrome, GracileSyndrome, Leigh Syndrome, MitochondrialComplex IIIDeficiency
|
AR,MI
|
99.96
|
40 of 42
|
BOLA3
|
Mitochondrial Dysfunctions Syndrome
|
AR
|
100
|
8 of 8
|
BRAF
|
Cardiofaciocutaneous Syndrome, Leopard Syndrome, Lung Cancer, Craniopharyngioma, Noonan Syndrome
|
AD
|
100
|
80 of 80
|
BRAT1
|
Neurodevelopmental Disorder, Cerebellar Atrophy, Rigidity And Multifocal Seizure Syndrome
|
AR
|
99.95
|
29 of 29
|
BRD2
|
Photosensitive Epilepsy
|
–
|
92.11
|
1 of 1
|
BTD
|
Biotinidase Deficiencymultiple Carboxylase Deficiency
|
AR
|
100
|
261 of 262
|
BUB1B
|
Colorectal Cancer, Mosaic Variegated Aneuploidy Syndrome
|
AD,AR
|
99.84
|
30 of 31
|
C12ORF57
|
Craniofacial Dysmorphism, Ocular Coloboma, Temtamy Syndrome
|
AR
|
–
|
–
|
CACNA1A
|
Epileptic Encephalopathy, Ataxia, Migraine, Benign Paroxysmal Torticollis Of Infancy
|
AD
|
96.13
|
249 of 266
|
CACNA1B
|
Neurodevelopmental Disorder, Seizures, Hyperkinetic Movements, Epileptic Encephalopathy
|
AR
|
95.83
|
7 of 7
|
CACNA1D
|
Primary Aldosteronism, Seizures, Neurologic Abnormalities, Sinoatrial Node Dysfunction, Deafness
|
AD,AR
|
100
|
18 of 18
|
CACNA1E
|
Epileptic Encephalopathy
|
AD
|
99.94
|
25 of 25
|
CACNA1H
|
Hyperaldosteronism, Epilepsy
|
AD
|
98.05
|
71 of 71
|
CACNA2D2
|
CerebellarAtrophy, Seizures, DevelopmentalDelay
|
AR
|
94
|
10 of 10
|
CACNB4
|
Epilepsy, Ataxia
|
AD
|
99.87
|
5 of 5
|
CAD
|
Epileptic Encephalopathy
|
AR
|
100
|
12 of 12
|
CARS2
|
Oxidative Phosphorylation Deficiency
|
AR
|
99.14
|
6 of 6
|
CASK
|
Anemia, Fg Syndrome, Mental Retardation, Microcephaly, Pontine And Cerebellar Hypoplasia, Epileptic Encephalopathy
|
X,XR,XD,G
|
99.98
|
–
|
CASR
|
Hyperparathyroidism, Hypocalcemia, Pancreatitis
|
AD,AR
|
100
|
445 of 446
|
CBL
|
Myelomonocytic Leukemia, Noonan Syndrome, Mastocytosis, Noonan Syndrome
|
AD
|
100
|
46 of 47
|
CC2D1A
|
Mental Retardation
|
AR
|
100
|
7 of 7
|
CC2D2A
|
Coach Syndrome, Joubert Syndrome, Meckel Syndrome
|
AR
|
99.43
|
98 of 100
|
CCDC88C
|
Hydrocephalus, Spinocerebellar Ataxia
|
AD,AR
|
99.44
|
13 of 14
|
CCL2
|
Neural TubeDefects
|
AD
|
100
|
–
|
CDK9
|
Inmune Deficiency Disease, Myeloma
|
–
|
82.69
|
2 of 2
|
CDKL5
|
Epileptic Encephalopathy, Atypical Rett Syndrome, West Syndrome
|
X,XD,G
|
99.92
|
–
|
CENPJ
|
Microcephaly, SeckelSyndrome
|
AR
|
99.97
|
13 of 13
|
CEP290
|
Bardet-Biedl Syndrome, Joubert Syndrome, Leber Congenital Amaurosis, Meckel Syndrome, Senior- Loken Syndrome
|
AR
|
96.47
|
293 of 327
|
CERS1
|
Epilepsy
|
AR
|
72.1
|
2 of 2
|
CERT1
|
Mental Retardation
|
AD
|
99.98
|
8 of 8
|
CHD2
|
Epileptic Encephalopathy, Lennox-Gastaut Syndrome
|
AD
|
98.91
|
103 of 103
|
CHRNA2
|
Epilepsy
|
AD
|
99.91
|
8 of 8
|
CHRNA4
|
Epilepsy
|
AD
|
99.8
|
24 of 24
|
CHRNB2
|
Epilepsy
|
AD
|
100
|
13 of 13
|
CILK1
|
Endocrine- Cerebroo- steodysplasia, Epilepsy
|
AD,AR
|
100
|
–
|
CLCN2
|
Epilepsy, Hyperaldosteronism, Leukoencephalopathy
|
AD,AR
|
100
|
39 of 39
|
CLCN4
|
Mental Retardation
|
X,XR,XD,G
|
99.69
|
–
|
CLN3
|
CeroidLipofuscinosis
|
AR
|
99.93
|
73 of 75
|
CLN5
|
CeroidLipofuscinosis
|
AR
|
99.56
|
52 of 55
|
CLN6
|
CeroidLipofuscinosis
|
AR
|
99.94
|
98 of 99
|
CLN8
|
CeroidLipofuscinosis, IntellectualDisability
|
AR
|
100
|
44 of 45
|
CLTC
|
Mental Retardation, Epileptic Encephalopathy
|
AD
|
98.81
|
14 of 14
|
CNKSR2
|
Mental Retardation, Epileptic Encephalopathy
|
X,G
|
99.11
|
–
|
CNPY3
|
Epileptic Encephalopathy, West Syndrome
|
AR
|
100
|
5 of 5
|
CNTN2
|
Epilepsy
|
AR
|
99.98
|
6 of 6
|
CNTNAP2
|
Pitt-Hopkins- LikeSyndrome
|
AR
|
99.91
|
39 of 41
|
COA7
|
Spinocerebellar Ataxia
|
AR
|
99.99
|
6 of 6
|
COA8
|
MitochondrialComplexIv Deficiency, Leukoencephalopathy
|
AR,MI
|
86.26
|
4 of 5
|
COG7
|
CongenitalDisorder Of Glycosylation
|
AR
|
99.94
|
6 of 6
|
COG8
|
CongenitalDisorder Of Glycosylation
|
AR
|
100
|
8 of 8
|
COL18A1
|
Glaucoma, KnoblochSyndrome
|
AD,AR
|
99.76
|
–
|
COL4A1
|
Angiopathy, Microangiopathy, Leukoencephalopathy, Porencephaly, Retinal Arteries, Hanac Syndrome, Walker-Warburg Syndrome
|
AD
|
99.99
|
173 of 173
|
COQ2
|
Coenzyme Q10 Deficiency, Multiple System Atrophy, Leigh Syndrome, Nephrotic Syndrome
|
AD,AR
|
99.61
|
37 of 38
|
COQ4
|
Coenzyme Q10 Deficiency
|
AR
|
91.05
|
21 of 21
|
COQ8A
|
Coenzyme Q10 Deficiency, Ataxia
|
AR
|
100
|
–
|
COQ9
|
Coenzyme Q10 Deficiency
|
AR
|
99.87
|
6 of 6
|
COX10
|
Leigh Syndrome, Mitochondrial Complex Iv Deficiency
|
AR,MI
|
100
|
13 of 13
|
COX15
|
Cardioence phalomyopathy, Leigh Syndrome, Leukodystrophy
|
AR,MI
|
100
|
5 of 5
|
COX6B1
|
Mitochondrial ComplexIv Deficiency
|
AR,MI
|
100
|
3 of 3
|
CPA6
|
Epilepsy, FebrileSeizures
|
AD,AR
|
99.97
|
9 of 9
|
CPLX1
|
Epileptic Encephalopathy, Wolf-Hirschhorn Syndrome
|
AD,AR
|
99.81
|
3 of 3
|
CPT2
|
Carnitine PalmitoyltransferaseIi Deficiency, Encephalopathy
|
AD,AR
|
99.99
|
116 of 116
|
CRH
|
Epilepsy, Conn Syndrome, Depression
|
–
|
99.84
|
1 of 2
|
CSF1R
|
BrainAbnormalities, Gliosis
|
AD,AR
|
100
|
122 of 124
|
CSNK2B
|
Poirier- Bienvenu Neurodevelopmental Syndrome
|
AD
|
99.98
|
14 of 17
|
CSTB
|
Epilepsy, Hypohidrotic Ectodermal Dysplasia, Unverricht-Lundborg Disease
|
AR
|
100
|
14 of 14
|
CTC1
|
Cerebroretinal Microangiopathy, DyskeratosisCongenita
|
AR
|
99.73
|
43 of 44
|
CTNND2
|
Benign Adult Familial Myoclonic Epilepsy
|
–
|
94.3
|
10 of 12
|
CTSA
|
Neuraminidase Deficiency, Galactosialidosis
|
AR
|
100
|
40 of 40
|
CTSD
|
CeroidLipofuscinosis
|
AR
|
100
|
18 of 18
|
CTSF
|
CeroidLipofuscinosis
|
AR
|
92.18
|
12 of 12
|
CUL4B
|
Mental Retardation, Short Stature, Musclewasting
|
X,XR,G
|
99.77
|
–
|
CUX2
|
Epileptic Encephalopathy, Lennox-Gastaut Syndrome
|
AD
|
99.72
|
2 of 2
|
CYFIP2
|
Epileptic Encephalopathy
|
AD
|
100
|
8 of 8
|
CYP27A1
|
Cerebrotendinous Xanthomatosis
|
AR
|
100
|
118 of 118
|
D2HGDH
|
D-2-Hydroxyglutaric Aciduria
|
AR
|
100
|
42 of 42
|
DARS1
|
Hypomyelination
|
AR
|
99.99
|
18 of 18
|
DARS2
|
Leuko encephalopathy
|
AR
|
100
|
65 of 65
|
DCX
|
Lissencephaly
|
X,G
|
100
|
–
|
DDC
|
Amino Acid Decarboxylase Deficiency
|
AR
|
100
|
59 of 59
|
DDX3X
|
Intellectual Developmental Disorder
|
X,XR,XD,G
|
99.03
|
–
|
DEAF1
|
Dyskinesia, Seizures, Intellectual Developmental Disorder, Smith- Magenis Syndrome
|
AD,AR
|
93.55
|
42 of 42
|
DEGS1
|
Leukodystrophy
|
AR
|
86.16
|
12 of 14
|
DENND5A
|
Epileptic Encephalopathy
|
AR
|
100
|
9 of 9
|
DEPDC5
|
Epilepsy
|
AD
|
100
|
127 of 127
|
DHCR7
|
Smith-Lemli- OpitzSyndrome
|
AR
|
100
|
217 of 217
|
DHDDS
|
Developmental Delay, Seizures, Retinitis Pigmentosa, Epileptic Encephalopathy
|
AD,AR
|
96.32
|
8 of 8
|
DHFR
|
Megaloblastic Anemia, Dihydrofolate Reductase Deficiency
|
AR
|
99.7
|
4 of 4
|
DHPS
|
Neurodevelopmenta Disorder, Seizures
|
AR
|
99.85
|
4 of 4
|
DIAPH1
|
Deafness, Seizures
|
AD,AR
|
99.94
|
15 of 15
|
DLD
|
Pyruvate Dehydrogenase Deficiency
|
AR
|
100
|
26 of 26
|
DNAJC5
|
Ceroid Lipofuscinosis
|
AD
|
100
|
2 of 2
|
DNM1
|
Epileptic Encephalopathy, Lennox-Gastaut Syndrome
|
AD
|
94.8
|
30 of 30
|
DNM1L
|
Encephalopathy, OpticAtrophy
|
AD,AR
|
100
|
29 of 29
|
DOCK7
|
EpilepticEncephalopathy, Cortical Blindness
|
AR
|
99.95
|
11 of 11
|
DOLK
|
Congenital Disorder Of Glycosylation, Dilated Cardiomyopathy
|
AR
|
99.98
|
13 of 13
|
DPAGT1
|
Congenital Disorder Of Glycosylation, Myasthenic Syndrome
|
AR
|
100
|
41 of 41
|
DPM1
|
CongenitalDisorder Of Glycosylation
|
AR
|
97.25
|
9 of 9
|
DPM2
|
Congenital Disorder Of Glycosylation, Muscular Dystrophy, Intellectual Disability, Epilepsy
|
AR
|
99.87
|
2 of 2
|
DPYD
|
Dihydropyrimidine Dehydrogenase Deficiency, 1p21.3 MicrodeletionSyndrome
|
AR
|
100
|
74 of 75
|
DPYS
|
Dihydropyrimidinuria
|
AR
|
100
|
31 of 31
|
DYNC1H1
|
Charcot-Marie-Tooth Disease, Mental Retardation, Spinal Muscular Atrophy
|
AD
|
100
|
104 of 104
|
DYRK1A
|
Mental Retardation
|
AD
|
99.85
|
78 of 81
|
EARS2
|
Oxidative Phosphorylation Deficiency
|
AR
|
98.8
|
31 of 31
|
ECHS1
|
Mitochondrial Short-Chain Enoyl-Coa Hydratase 1 Deficiency, Leigh Syndrome, Leukodystrophy
|
AR
|
100
|
39 of 39
|
ECM1
|
LipoidProteinosis
|
AR
|
99.99
|
64 of 64
|
EEF1A2
|
EpilepticEncephalopathy, Mental Retardation
|
AD
|
100
|
14 of 14
|
EFHC1
|
Epilepsy
|
AD
|
100
|
38 of 39
|
EHMT1
|
KleefstraSyndrome
|
AD
|
98.58
|
58 of 75
|
EIF2B1
|
Leukoencephalopathy, Vanishing White Matter
|
AR
|
100
|
9 of 9
|
EIF2B2
|
Leukoencephalopathy, Vanishing White Matter
|
AR
|
100
|
30 of 30
|
EIF2B3
|
Leukoencephalopathy, Vanishing White Matter
|
AR
|
97.55
|
26 of 26
|
EIF2B4
|
Leukoencephalopathy, Vanishing White Matter
|
AR
|
100
|
31 of 31
|
EIF2B5
|
Leukoencephalopathy, Vanishing White Matter
|
AR
|
100
|
99 of 99
|
EIF3F
|
Intellectual Developmental Disorder
|
AR
|
99.99
|
1 of 1
|
EMX2
|
Schizencephaly
|
–
|
100
|
5 of 5
|
EPM2A
|
LaforaDisease
|
AR
|
89.2
|
63 of 70
|
EPRS1
|
Leukodystrophy
|
AR
|
99.62
|
6 of 6
|
ETFA
|
Acyl-Coa Dehydrogenase Deficiency
|
AR
|
92.33
|
32 of 32
|
ETFB
|
Acyl-Coa Dehydrogenase Deficiency
|
AR
|
100
|
21 of 21
|
ETFDH
|
Acyl-Coa Dehydrogenase Deficiency
|
AR
|
100
|
221 of 222
|
ETHE1
|
Encephalopathy
|
AR
|
100
|
32 of 33
|
FA2H
|
Spastic Paraplegia, Fatty Acid Hydroxylase- Associated Neurodegeneration
|
AR
|
88.77
|
60 of 62
|
FAM126A
|
Hypomyelination, CongenitalCataract
|
AR
|
100
|
11 of 12
|
FAR1
|
Fatty Acyl-Coa Reductase 1 Deficiency
|
AR
|
98.77
|
4 of 4
|
FARS2
|
Oxidative Phosphorylation Deficiency, Spastic Paraplegia
|
AR
|
99.98
|
23 of 23
|
FASN
|
FattyLiverDisease
|
–
|
100
|
6 of 6
|
FCSK
|
CongenitalDisorder Of Glycosylation
|
AR
|
97.99
|
–
|
FDFT1
|
SqualeneSynthase Deficiency
|
AR
|
99.77
|
3 of 4
|
FDX2
|
MitochondrialMyopathy, Leukoencephalopathy
|
AR,MI
|
100
|
–
|
FGD1
|
Aarskog-Scott Syndrome
|
X,XR,G
|
98.95
|
–
|
FGF12
|
EpilepticEncephalopathy
|
AD
|
99.98
|
4 of 6
|
FGFR3
|
Achondroplasia, Hypochondroplasia, Camptodactyly, CrouzonSyndrome, Epidermal Nevus, Lacrimoauricul odentodigital Syndrome, MuenkeSyndrome, Thanatophoric Dysplasia, IsolatedBrachycephaly, IsolatedPlagiocephaly, Saethre-Chotzen Syndrome
|
AD,AR
|
99.89
|
77 of 78
|
FH
|
FumaraseDeficiency, Leiomyomatosis
|
AD,AR
|
100
|
229 of 232
|
FKRP
|
Dystroglycanopathy, Limb-Girdle Muscular Dystrophy, Muscle- Eye-Brain Disease, Walker-Warburg Syndrome
|
AR
|
99.9
|
157 of 157
|
FKTN
|
Cardiomyopathy, Dystroglycanopathy, Limb-Girdle Muscular Dystrophy, Muscle- Eye-Brain Disease, Walker-Warburg Syndrome
|
AR
|
98
|
54 of 56
|
FLNA
|
Cardiac Valvular Dysplasia, FgSyndrome, Frontometaphyseal Dysplasia, Heterotopia, Intestinal Pseudoobstruction, Melnick-NeedlesSyndrome, OtopalatodigitalSyndrome, Terminal OsseousDysplasia, Short BowelSyndrome, Ehlers-Danlos Syndrome
|
X,XR,XD,G
|
100
|
–
|
FOLR1
|
Neurodegeneration
|
AR
|
100
|
19 of 23
|
FOXG1
|
Rett Syndrome, 14q12 Microdeletion Syndrome
|
AD
|
88.71
|
93 of 109
|
FOXRED1
|
Mitochondrial Complex I Deficiency, Leigh Syndrome, Leukodystrophy
|
AR
|
100
|
13 of 13
|
FRRS1L
|
EpilepticEncephalopathy, IntellectualDisability
|
AR
|
85.58
|
7 of 7
|
FUCA1
|
Fucosidosis
|
AR
|
100
|
31 of 32
|
FUT8
|
Congenital Disorder Of Glycosylation, Fucosylation
|
AR
|
99.73
|
4 of 4
|
GABBR2
|
Epileptic Encephalopathy, Neurodevelopmental Disorder, Rett Syndrome
|
AD
|
95.98
|
7 of 7
|
GABRA1
|
EpilepticEncephalopathy, DravetSyndrome
|
AD
|
100
|
45 of 46
|
GABRA2
|
Alcohol Dependence, Epileptic Encephalopathy
|
AD,MU
|
99.08
|
3 of 3
|
GABRA3
|
ThyrotoxicPeriodic Paralysis
|
–
|
99.91
|
–
|
GABRA5
|
Epileptic Encephalopathy
|
AD
|
99.94
|
9 of 9
|
GABRB1
|
Epileptic Encephalopathy
|
AD
|
99.98
|
9 of 9
|
GABRB2
|
Epileptic Encephalopathy
|
AD
|
99.19
|
16 of 19
|
GABRB3
|
EpilepticEncephalopathy, Lennox-Gastaut Syndrome
|
AD
|
100
|
54 of 62
|
GABRD
|
Epilepsy, 1p36 DeletionSyndrome
|
AD
|
|
3 of 3
|
GABRG2
|
EpilepticEncephalopathy, DravetSyndrome
|
AD
|
99.67
|
53 of 53
|
GAL
|
Epilepsy
|
AD
|
100
|
1 of 1
|
GALC
|
KrabbeDisease
|
AR
|
99.38
|
252 of 254
|
GAMT
|
Cerebral Creatine DeficiencySyndrome, Guanidinoacetate Methyltransferase Deficiency
|
AR
|
99.92
|
60 of 60
|
GATM
|
Cerebral Creatine Deficiency Syndrome , Fanconi Renotubular Syndrome
|
AD,AR
|
99.98
|
21 of 21
|
GCDH
|
Glutaric Acidemia, Glutaryl-Coa Dehydrogenase Deficiency
|
AR
|
88.74
|
254 of 254
|
GCH1
|
Dystonia, GtpCyclohydrolase I Deficiency
|
AD,AR
|
99.41
|
225 of 244
|
GCSH
|
Glycine Encephalopathy
|
AR
|
93.52
|
1 of 1
|
GFAP
|
Alexander Disease
|
AD
|
99.98
|
143 of 143
|
GFM1
|
CombinedOxidative Phosphorylation Deficiency
|
AR
|
100
|
27 of 27
|
GFM2
|
CombinedOxidative Phosphorylation Deficiency
|
AR
|
99.35
|
5 of 7
|
GJC2
|
Leukodystrophy, Lymphedema, Spastic Paraplegia, Milroy Disease
|
AD,AR
|
95.37
|
52 of 63
|
GLB1
|
Gangliosidosis, Morquio Syndrome
|
AR
|
100
|
242 of 243
|
GLDC
|
Glycine Encephalopathy
|
AR
|
98.69
|
359 of 367
|
GLI2
|
Holoprosencephaly, Pallister-Hall Syndrome, Pituitary Hormone Deficiencies
|
AD
|
98.38
|
83 of 88
|
GLI3
|
GreigCephalopolysyndactyly Syndrome, Hypothalamic Hamartomascongenital Hypothalamic HamartomaSyndrome, Pallister-Hall Syndrome, AcrocallosalSyndrome, Tibial Hemimelia
|
AD,AR
|
100
|
231 of 231
|
GLRA1
|
Hyperekplexia
|
AD,AR
|
99.6
|
71 of 72
|
GLRB
|
Hyperekplexia
|
AR
|
99.3
|
16 of 18
|
GLS
|
Epileptic Encephalopathy, Global Developmental Delay, Infantile Cataract
|
AD,AR
|
97.77
|
8 of 9
|
GLUD1
|
Hyperinsulinemic Hypoglycemia, Hyperinsulinism- Hyperammonemia Syndrome
|
AD
|
99.98
|
39 of 39
|
GNAO1
|
EpilepticEncephalopathy, Neurodevelopmental Disorder
|
AD
|
100
|
47 of 47
|
GNB1
|
Leukemia, Mental Retardation, Global Developmental Delay
|
AD,MU,P
|
100
|
31 of 31
|
GNE
|
Nonaka Myopathy, Sialuria
|
AD,AR
|
99.97
|
248 of 253
|
GNS
|
Mucopoly saccharidosis
|
AR
|
99.92
|
22 of 22
|
GOLGA2
|
Vohwinkel Syndrome, Smith-Mccort Dysplasia
|
–
|
99.89
|
3 of 3
|
GOSR2
|
Epilepsy
|
AR
|
88.39
|
6 of 6
|
GPAA1
|
Glycosylphosphatidylinositol Biosynthesis Defect, Neurodevelopmental Delay
|
AR
|
99.98
|
11 of 11
|
GPC3
|
Simpson-Golabi-Behmel Syndrome, Wilms Tumor Nephroblastoma
|
AD,X,XR,G
|
99.84
|
–
|
GPHN
|
Hyperekplexia, Molybdenum Cofactor Deficiency
|
AD,AR
|
99.2
|
6 of 6
|
GRIA3
|
Mental Retardation
|
X,XR,G
|
98.39
|
–
|
GRIA4
|
Neurodevelopmental Disorder
|
AD
|
99.94
|
5 of 5
|
GRIK2
|
Mental Retardation
|
AR
|
96.98
|
5 of 6
|
GRIN1
|
Neurodevelopmental Disorder
|
AD,AR
|
100
|
43 of 43
|
GRIN2A
|
Epileptic Encephalopathy
|
AD
|
100
|
143 of 143
|
GRIN2B
|
Epileptic Encephalopathy, Mental Retardation, West Syndrome
|
AD
|
99.99
|
108 of 108
|
GRIN2D
|
Epileptic Encephalopathy
|
AD
|
79.74
|
17 of 18
|
GRN
|
CeroidLipofuscinosis, Frontotemporal Lobar Degeneration, SemanticDementia
|
AD,AR
|
100
|
220 of 229
|
GTPBP3
|
Oxidative Phosphorylation Deficiency
|
AR
|
99.94
|
17 of 17
|
GUF1
|
Epileptic Encephalopathy, West Syndrome
|
AR
|
99.88
|
4 of 4
|
HACE1
|
Neuroblastoma, Spastic Paraplegia, Developmental Delay, Epilepsy
|
AR
|
100
|
15 of 15
|
HCN1
|
Epileptic Encephalopathy
|
AD
|
98.43
|
42 of 43
|
HCN2
|
Epilepsy, Retinitis Pigmentosa
|
–
|
70.45
|
6 of 9
|
HCN4
|
Brugada Syndrome, SickSinusSyndrome
|
AD
|
98.01
|
40 of 41
|
HDAC4
|
2q37 Microdeletion Syndrome
|
–
|
100
|
10 of 10
|
HECW2
|
Neurodevelopmental Disorder, Hypotonia, Seizures
|
AD
|
99.85
|
13 of 13
|
HEPACAM
|
Megalencephalic Leukoencephalopathy
|
AD,AR
|
97.87
|
30 of 30
|
HEXA
|
Tay-Sachs Disease
|
AR
|
100
|
205 of 206
|
HEXB
|
Sandhoff Disease
|
AR
|
99.92
|
109 of 115
|
HGSNAT
|
Mucopolysaccharidosis, Retinitis Pigmentosa
|
AR
|
87.91
|
69 of 73
|
HIBCH
|
3-Hydroxyisobutyryl-Coa HydrolaseDeficiency, Neurodegeneration
|
AR
|
96.47
|
27 of 27
|
HNRNPU
|
EpilepticEncephalopathy, 1q44 Microdeletion Syndrome
|
AD
|
99.8
|
36 of 36
|
HPD
|
Hawkinsinuria , Tyrosinemia
|
AD,AR
|
100
|
10 of 10
|
HRAS
|
Bladder Cancer, Costello Syndrome, Epidermal Nevus, Giant Pigmented Hairy Nevus, Schimmelpenning- Feuerstein-Mims Syndrome, Linear Nevus Sebaceus Syndrome
|
AD
|
100
|
34 of 34
|
HSD17B10
|
Hydroxyacyl-Coa DehydrogenaseIi Deficiency
|
X,XD,G
|
100
|
–
|
HSD17B4
|
D-Bifunctional Protein Deficiency, Perrault Syndrome
|
AR
|
99.52
|
85 of 85
|
HSPD1
|
Leukodystrophy SpasticParaplegia
|
AD,AR
|
100
|
7 of 7
|
HTRA1
|
Cerebral Arteriopathy, Leukoencephalopathy
|
AD,AR
|
87.47
|
55 of 57
|
HTT
|
Huntington Disease, Lopes-Maciel-Rodan Syndrome
|
AD,AR
|
99
|
–
|
IBA57
|
Multiple Mitochondrial Dysfunctions Syndrome, Spastic Paraplegia
|
AR
|
93.35
|
25 of 27
|
IDH2
|
D-2-Hydroxyglutaric Aciduria, Maffucci Syndrome, Ollier Disease
|
AD
|
99.99
|
4 of 4
|
IDS
|
Mucopolysaccharidosis
|
X,XR,G
|
99.86
|
–
|
IER3IP1
|
Microcephaly, Epilepsy
|
AR
|
99.97
|
5 of 5
|
IQSEC2
|
Mental Retardation, Microduplication Xp11.22p11.23 Syndrome, Smith- Magenis Syndrome
|
X,XR,XD,G
|
99.73
|
–
|
IRF2BPL
|
Neurodevelopmental Disorder, Seizures
|
AD
|
95.01
|
24 of 25
|
ITPA
|
Epileptic Encephalopathy
|
AR
|
100
|
5 of 6
|
JMJD1C
|
22q11.2 Deletion Syndrome
|
–
|
99.09
|
27 of 27
|
JRK
|
Epilepsy
|
–
|
–
|
–
|
KANSL1
|
Koolen-De Vries Syndrome
|
AD
|
96.03
|
22 of 27
|
KCNA1
|
Ataxia, Epileptic Encephalopathy, Continuous Muscle Fiber Activity, Paroxysmal Kinesigenic Dyskinesia
|
AD
|
100
|
49 of 49
|
KCNA2
|
Epileptic Encephalopathy
|
AD
|
99.86
|
23 of 23
|
KCNAB2
|
1p36 Deletion Syndrome
|
–
|
79
|
3 of 3
|
KCNB1
|
Epileptic Encephalopathy
|
AD
|
99.95
|
55 of 55
|
KCNC1
|
Epilepsy
|
AD
|
99.87
|
10 of 10
|
KCND2
|
Autism, Epileptic Encephalopathy
|
–
|
100
|
4 of 4
|
KCNH1
|
Temple-Baraitser Syndrome, Zimmermann-Laband Syndrome
|
AD
|
99.69
|
15 of 15
|
KCNH2
|
Long Qt Syndrome, Short Qt Syndrome, Romano-Ward Syndrome
|
AD
|
98.69
|
908 of 930
|
KCNH5
|
Epileptic
Encephalopathy, Neuropathy
|
–
|
98.72
|
1 of 1
|
KCNJ10
|
Enlarged Vestibular Aqueduct, Pendred Syndrome, Seizures, East Syndrome
|
AR
|
93.53
|
27 of 32
|
KCNJ11
|
Diabetes Mellitus, Hyperinsulinemic Hypoglycemia, Maturity-Onset Diabetes Of The Young, Hyperinsulinism, Dend Syndrome
|
AD,AR
|
100
|
190 of 191
|
KCNK4
|
Facial Dysmorphism, Epilepsy, Gingival Overgrowth
|
AD
|
94.93
|
2 of 2
|
KCNMA1
|
Cerebellar Atrophy, Epilepsy, Paroxysmal Dyskinesia, Liang-Wang Syndrome
|
AD,AR
|
99.98
|
24 of 26
|
KCNQ2
|
Epileptic Encephalopathy
|
AD
|
99.94
|
333 of 334
|
KCNQ3
|
Epilepsy
|
AD
|
97.94
|
40 of 40
|
KCNQ5
|
Mental Retardation
|
AD
|
95.08
|
8 of 8
|
KCNT1
|
Epileptic Encephalopathy
|
AD
|
95.98
|
64 of 64
|
KCNT2
|
Epileptic Encephalopathy
|
AD
|
98.26
|
4 of 4
|
KCNV2
|
Retinal ConeDystrophy
|
AR
|
99.98
|
86 of 88
|
KCTD3
|
Variegate Porphyria , Niemann- Pick Disease
|
–
|
96.19
|
2 of 2
|
KCTD7
|
Epilepsy
|
AR
|
99.99
|
40 of 40
|
KDM5C
|
Mental Retardation
|
X,XR,G
|
100
|
–
|
KDM6A
|
Kabuki Syndrome
|
AD,X,XD,G
|
99.98
|
–
|
KIF1A
|
Mental Retardation, Neuropathy, Spastic Paraplegia, Peho Syndrome
|
AD,AR
|
100
|
76 of 76
|
KIFBP
|
Goldberg- ShprintzenSyndrome
|
AR
|
99.27
|
–
|
KMT2D
|
Kabuki Syndrome
|
AD
|
99.71
|
839 of 847
|
KMT2E
|
O’donnell-Luria- Rodan Syndrome, Intellectual Disability
|
AD
|
99.83
|
34 of 34
|
KPNA7
|
CerebellarMalformation, Cerebellar Vermis Hypoplasia
|
–
|
100
|
3 of 3
|
KRAS
|
Aplasia Cutis Congenita, Cardiofaciocutaneous Syndrome, Leukemia, Noonan Syndrome, Autoimmune Lymphoproliferative Syndrome, Schimmelpenning- Feuerstein-MimsSyndrome, Encephalocraniocutaneous Lipomatosis, Linear Nevus SebaceusSyndrome, Lynch Syndrome, Toriello-Lacassie- DrosteSyndrome
|
AD
|
100
|
38 of 38
|
L2HGDH
|
L-2-Hydroxyglutaric Aciduria
|
AR
|
100
|
72 of 73
|
LAMA2
|
Limb-Girdle Muscular Dystrophy
|
AR
|
100
|
363 of 377
|
LBR
|
Hydrops-Ectopic Calcification-Moth- Eaten Skeletal Dysplasia, Pelger-Huet Anomaly, Reynolds Syndrome, Greenberg Dysplasia, Reynolds Syndrome
|
AD,AR
|
99.98
|
34 of 34
|
LGI1
|
Epilepsy
|
AD
|
99.94
|
54 of 54
|
LIAS
|
Pyruvate Dehydrogenase LipoicAcidSynthetase Deficiency
|
AR
|
99.82
|
8 of 8
|
LMNB1
|
Leukodystrophy
|
AD
|
99.66
|
4 of 4
|
LMNB2
|
Barraquer-Simons Syndrome, Epilepsy, Acquired Partial Lipodystrophy
|
AD,AR
|
95.03
|
5 of 5
|
LNPK
|
Neurodevelopmental Disorder With Epilepsy And Hypoplasia Of The Corpus Callosum
|
AR
|
99.26
|
–
|
LRPPRC
|
Leigh Syndrome
|
AR
|
98.94
|
18 of 18
|
LYRM7
|
Mitochondrial ComplexIii Deficiency
|
AR
|
99.86
|
9 of 9
|
MACF1
|
Lissencephaly
|
AD
|
99.94
|
18 of 18
|
MAGI2
|
Nephrotic Syndrome
|
AR
|
93.82
|
7 of 9
|
MAP2K1
|
Cardiofaciocutaneous Syndrome, Melorheostosis, Noonan Syndrome
|
AD
|
100
|
31 of 31
|
MAP2K2
|
Cardiofaciocutaneous Syndrome, Neurofibromatosis- Noonan Syndrome
|
AD
|
100
|
37 of 37
|
MAPK10
|
Lennox- GastautSyndrome
|
–
|
99.97
|
–
|
MARCHF6
|
Epilepsy
|
AD
|
99.97
|
–
|
MARS2
|
Ataxia, Oxidative Phosphorylation Deficiency, Spastic Ataxia With Leukoencephalopathy
|
AR
|
99.94
|
3 of 3
|
MBD5
|
2q23.1 Microdeletion Syndrome
|
AD
|
99.99
|
33 of 35
|
MBOAT7
|
Mental Retardation
|
AR
|
99.08
|
11 of 12
|
MCOLN1
|
Mucolipidosis
|
AR
|
99.99
|
34 of 36
|
MCPH1
|
Microcephaly
|
AR
|
99.51
|
18 of 19
|
MDH2
|
EpilepticEncephalopathy, Pheochromocytoma- Paraganglioma
|
AR
|
98
|
11 of 11
|
ME2
|
Epilepsy, Li- FraumentiSyndrome
|
–
|
99.99
|
1 of 1
|
MECP2
|
Autism, Encephalopathy, Lubs Mental Retardation Syndrome, Rett Syndrome, Trisomy Xq28
|
X,XR,XD,MU,G
|
99.81
|
–
|
MED12
|
Lujan-Fryns Syndrome, Ohdo Syndrome, Opitz- Kaveggia Syndrome, Blepharophimosis- Intellectual Disability Syndrome, Fg Syndrome
|
X,XR,G
|
100
|
–
|
MED17
|
Microcephaly
|
AR
|
100
|
9 of 9
|
MEF2C
|
Mental Retardation, Stereotypic Movements, Epilepsy, Cerebralmalformations, 5q14.3 Microdeletion Syndrome
|
AD
|
99.91
|
43 of 46
|
MFSD8
|
CeroidLipofuscinosis, Macular Dystrophy
|
AR
|
100
|
63 of 63
|
MGAT2
|
CongenitalDisorder Of Glycosylation
|
AR
|
97.19
|
5 of 5
|
MICAL1
|
Epilepsy
|
AD
|
99.98
|
3 of 3
|
MIPEP
|
CombinedOxidative Phosphorylation Deficiency
|
AR
|
99.84
|
7 of 8
|
MLC1
|
Megalencephalic Leukoencephalopathy
|
AR
|
100
|
104 of 106
|
MOCS1
|
Molybdenum Cofactor Deficiency
|
AR
|
100
|
36 of 37
|
MOCS2
|
Molybdenum Cofactor Deficiency
|
AR
|
100
|
32 of 32
|
MOGS
|
CongenitalDisorder Of Glycosylation
|
AR
|
100
|
10 of 10
|
MPDU1
|
CongenitalDisorder Of Glycosylation
|
AR
|
100
|
7 of 7
|
MRPL44
|
Oxidative Phosphorylation Deficiency
|
AR
|
99.75
|
2 of 2
|
MTFMT
|
Oxidative Phosphorylation Deficiency, Mitochondrial Complex I Deficiency, Leigh Syndrome With Leukodystrophy
|
AR
|
99.52
|
18 of 18
|
MTHFR
|
Homocystinuria, Neural Tube Defects, Schizophrenia, Thrombophiliavenous Thromboembolism, Isolated Anencephaly , Isolated Exencephaly
|
AD,AR
|
100
|
122 of 122
|
MTHFS
|
Neurodevelopmental Disorder With Microcephaly, Epilepsy, Hypomyelination
|
AR
|
100
|
5 of 5
|
MTOR
|
Dysplasia Of Taylor, Smith-Kingsmore Syndrome, Macrocephaly- Intellectual Disability- Neurodevelopmental Disorder-Small Thorax Syndrome
|
AD
|
99.98
|
39 of 39
|
NACC1
|
Neurodevelopmental Disorder With Epilepsy, Cataracts, Feeding Difficulties, Delayed Brain Myelination
|
AD
|
99.99
|
3 of 3
|
NAGLU
|
Charcot-Marie-Tooth Disease, Mucopoly saccharidosis
|
AD,AR
|
93.23
|
194 of 222
|
NBEA
|
Autism, Oxidative Phosphorylation Deficiency
|
–
|
99.48
|
27 of 27
|
NDE1
|
Lissencephaly, Microhydranencephaly
|
AR
|
86.55
|
12 of 13
|
NDST1
|
Mental Retardation
|
AR
|
99.99
|
11 of 11
|
NDUFA1
|
MitochondrialComplex I Deficiency
|
X,XR,G
|
100
|
–
|
NDUFA2
|
Mitochondrial Complex I Deficiency, Leigh Syndrome With Leukodystrophy
|
AR
|
99.84
|
2 of 3
|
NDUFAF3
|
Mitochondrial Complex I Deficiency, Leigh Syndrome With Cardiomyopathy
|
AR
|
100
|
9 of 9
|
NDUFAF5
|
Mitochondrial Complex I Deficiency, Leigh Syndrome With Leukodystrophy
|
AR
|
100
|
13 of 14
|
NDUFAF6
|
Fanconi Renotubular Syndrome, Mitochondrial Complex I Deficiency, Leigh Syndrome With Leukodystrophy
|
AR
|
99.4
|
12 of 13
|
NDUFS1
|
Mitochondrial Complex I Deficiency, Leigh Syndrome With Leukodystrophy
|
AR
|
99.98
|
30 of 30
|
NDUFS2
|
Mitochondrial Complex I Deficiency, Leber Hereditary Optic Neuropathy, Leigh Syndrome With Cardiomyopathy, Leukodystrophy
|
AR
|
100
|
26 of 26
|
NDUFS3
|
Mitochondrial Complex I Deficiency, Leigh Syndrome With Leukodystrophy
|
AR
|
93.67
|
4 of 4
|
NDUFS4
|
Mitochondrial Complex I Deficiency, Leigh Syndrome With Leukodystrophy
|
AR,X,XD,MI,G
|
100
|
15 of 15
|
NDUFS6
|
MitochondrialComplex I Deficiency
|
AR
|
100
|
6 of 6
|
NDUFS7
|
Mitochondrial Complex I Deficiency, Leigh Syndrome With Leukodystrophy
|
AR
|
88
|
6 of 7
|
NDUFS8
|
Mitochondrial Complex I Deficiency, Leigh Syndrome With Leukodystrophy
|
AR
|
100
|
16 of 16
|
NDUFV1
|
Mitochondrial Complex I Deficiency, Leigh Syndrome With Leukodystrophy
|
AR
|
100
|
36 of 36
|
NECAP1
|
EpilepticEncephalopathy
|
AR
|
99.83
|
2 of 2
|
NEDD4L
|
Periventricular Nodular Heterotopia
|
AD
|
97.61
|
10 of 10
|
NEU1
|
NeuraminidaseDeficiency, Sialidosis
|
AR
|
100
|
68 of 68
|
NEUROD2
|
Epileptic Encephalopathy
|
AD
|
96.88
|
2 of 2
|
NEXMIF
|
Mental Retardation
|
X,XR,XD,G
|
99.74
|
–
|
NF1
|
JuvenileMyelomonocytic Leukemia, Neurofibromatosis- NoonanSyndrome, Watson Syndrome, 17q11.2 MicroduplicationSyndrome, Pheochromocytoma- Paraganglioma
|
AD
|
97.97
|
3082 of 3166
|
NFU1
|
MultipleMitochondrial Dysfunctions Syndrome
|
AR
|
100
|
13 of 15
|
NGLY1
|
Congenital Disorder Of Glycosylation, Alacrimia- Choreoathetosis- Liver Dysfunction Syndrome
|
AR
|
|
28 of 28
|
NHLRC1
|
LaforaDisease
|
AR
|
100
|
71 of 71
|
NIPBL
|
Cornelia De Lange Syndrome
|
AD
|
99.32
|
409 of 426
|
NKX6-2
|
Spastic Ataxia, Hypomyelinating Leukodystrophy
|
AR
|
82.95
|
8 of 9
|
NOTCH3
|
Cerebral Arteriopathy, Leukoencephalopathy, Lateral Meningocele Syndrome, Myofibromatosis, Myofibromatosis
|
AD
|
96.31
|
398 of 399
|
NPC1
|
Niemann-Pick Disease
|
AR
|
97
|
503 of 505
|
NPC2
|
Niemann-Pick Disease
|
AR
|
100
|
27 of 27
|
NPHP1
|
Joubert Syndrome, Nephronophthisis, Senior-Loken Syndrome, Bardet- Biedl Syndrome, Joubert Syndrome With Renal Defect
|
AR
|
100
|
58 of 59
|
NPRL2
|
Epilepsy
|
AD
|
100
|
12 of 12
|
NPRL3
|
Epilepsy
|
AD
|
99.61
|
18 of 18
|
NR2F1
|
Bosch-Boonstra Optic Atrophy Syndrome
|
AD
|
89.78
|
26 of 31
|
NRXN1
|
Pitt-Hopkins- LikeSyndrome
|
AR
|
97.42
|
33 of 74
|
NSD1
|
Sotos Syndrome, 5q35 Microduplication Syndrome, Weaver Syndrome
|
AD
|
99.8
|
451 of 459
|
NT5C2
|
SpasticParaplegia
|
AR
|
97.89
|
6 of 7
|
NTNG1
|
Atypical Rett Syndrome
|
–
|
99.96
|
2 of 2
|
NTRK2
|
Epileptic Encephalopathy, Obesity, Hyperphagia, Developmental Delay, West Syndrome
|
AD
|
100
|
9 of 9
|
NUBPL
|
MitochondrialComplex I Deficiency
|
AR
|
95.2
|
13 of 13
|
NUS1
|
Congenital Disorder Of Glycosylation, Mental Retardation, Epileptic Encephalopathy
|
AD,AR
|
99.62
|
22 of 23
|
OFD1
|
Joubert Syndrome, Orofaciodigital Syndrome, Retinitis Pigmentosa, Simpson-Golabi-Behmel Syndrome, Primary Ciliary Dyskinesia
|
X,XR,XD,G
|
98.09
|
–
|
OPHN1
|
Mental Retardation, CerebellarHypoplasia, Distinctivefacial Appearance
|
X,XR,G
|
100
|
–
|
P4HTM
|
Hypotonia, Hyperventilation, Impaired Intellectual Development, Dysautonomia, Epilepsy, Eye Abnormalities
|
AR
|
92.81
|
5 of 5
|
PACS1
|
Intellectual Disability- Craniofacial Dysmorphism- Cryptorchidism Syndrome
|
AD
|
97.98
|
3 of 3
|
PACS2
|
Epileptic Encephalopathy
|
AD
|
99.52
|
3 of 3
|
PAFAH1B1
|
17p13.3 Microduplication Syndrome, Lissencephaly, Miller-Dieker Syndrome
|
AD
|
99.95
|
90 of 92
|
PAK3
|
Mental Retardation
|
X,XR,G
|
99.96
|
–
|
PANK2
|
Hypoprebetalipo proteinemia, Acanthocytosis, Retinitis Pigmentosa, Pallidal Degeneration, Neurodegeneration, Pantothenate Kinase- Associated Neurodegeneration
|
AR
|
98.92
|
177 of 182
|
PARS2
|
Epileptic Encephalopathy
|
AR
|
100
|
7 of 7
|
PC
|
PyruvateCarboxylase Deficiency
|
AR
|
100
|
48 of 48
|
PCDH19
|
Epilepsy, DravetSyndrome
|
X,G
|
99.99
|
–
|
PCNT
|
Microcephalic Osteodysplastic Primordial Dwarfism, Seckel Syndrome
|
AR
|
99.92
|
103 of 105
|
PDHA1
|
Pyruvate Decarboxylase Deficiency, Leigh Syndrome With Leukodystrophy
|
X,XD,G
|
99.02
|
–
|
PDSS2
|
Coenzyme Q10 Deficiency, Leigh Syndrome With Nephrotic Syndrome
|
AR
|
99.99
|
6 of 6
|
PEX1
|
Hearing Loss With Enamel Hypoplasia And Nail Defects, Peroxisome Biogenesis Disorder, Zellweger Syndrome, Refsum Disease, Neonatal Adrenoleukodystrophy
|
AR
|
97.02
|
126 of 134
|
PEX10
|
Zellweger Syndrome, Refsum Disease, Neonatal Adrenoleukodystrophy
|
AR
|
99.76
|
29 of 32
|
PEX12
|
Zellweger Syndrome, Refsum Disease, Neonatal Adrenoleukodystrophy
|
AR
|
100
|
38 of 38
|
PEX14
|
Refsum Disease, Neonatal Adrenoleukodystrophy, Zellweger Syndrome
|
AR
|
100
|
4 of 4
|
PEX2
|
Refsum Disease, Neonatal Adrenoleukodystrophy, Zellweger Syndrome
|
AR
|
99.89
|
17 of 17
|
PEX26
|
Refsum Disease, Neonatal Adrenoleukodystrophy, Zellweger Syndrome
|
AR
|
100
|
29 of 29
|
PEX3
|
Refsum Disease, Neonatal Adrenoleukodystrophy, Zellweger Syndrome
|
AR
|
100
|
9 of 9
|
PEX5
|
Adrenoleukodystrophy, Cerebrohepatorenal Syndrome, Rhizomelic Chondrodysplasia Punctata, Refsum Disease, ZellwegerSyndrome
|
AR
|
100
|
12 of 12
|
PEX6
|
HeimlerSyndrome, Spinocerebellar Ataxia- Blindness-Deafness Syndrome, Deafness- EnamelHypoplasia- NailDefectsSyndrome, RefsumDisease, Neonatal Adrenoleukodystrophy, ZellwegerSyndrome
|
AD,AR
|
99.94
|
105 of 108
|
PEX7
|
ZellwegerSyndrome, Rhizomelic Chondrodysplasia Punctata, RefsumDisease
|
AR
|
99.21
|
47 of 53
|
PGK1
|
Phosphoglycerate Kina se 1 Deficiency, Glycogen Storage Disease
|
X,XR,G
|
100
|
–
|
PHACTR1
|
Epileptic Encephalopathy, West Syndrome
|
AD
|
99.89
|
5 of 5
|
PHF6
|
Borjeson-Forssman- Lehmann Syndrome
|
X,XR,G
|
99.93
|
–
|
PIGA
|
Paroxysmal Nocturnal Hemoglobinuria, West Syndrome
|
X,XR,G
|
97.98
|
–
|
PIGB
|
Epileptic Encephalopathy
|
AR
|
99.97
|
10 of 10
|
PIGC
|
Glycosyl phosphatidylinositol BiosynthesisDefect
|
AR
|
99.59
|
4 of 4
|
PIGG
|
Epilepsy-Intellectual Disability-Brain Anomalies Syndrome
|
AR
|
99.86
|
6 of 6
|
PIGN
|
Fryns Syndrome, Multiple Congenital Anomalies-Hypotonia- Seizures Syndrome
|
AR
|
93.97
|
36 of 39
|
PIGO
|
Hyperphosphatasia With Mental Retardation Syndrome
|
AR
|
99.93
|
21 of 21
|
PIGP
|
Epileptic Encephalopathy
|
AR
|
99.98
|
2 of 2
|
PIGQ
|
Epileptic Encephalopathy
|
AR
|
99.99
|
4 of 4
|
PIGS
|
Glycosylphos phatidylinositol Biosynthesis Defect
|
AR
|
100
|
6 of 6
|
PIGT
|
Paroxysmal Nocturnal Hemoglobinuria, Intellectual Disability- Seizures- Hypophosphatasia- Ophthalmic-Skeletal Anomalies Syndrome
|
AD,AR
|
100
|
15 of 15
|
PIGV
|
Hyperphosphatasia- Intellectual Disability Syndrome
|
AR
|
99.99
|
16 of 16
|
PIGW
|
Hyperphosphatasia- IntellectualDisability Syndrome
|
AR
|
99.52
|
6 of 6
|
PIK3AP1
|
Bissinosis, Central Nervous System Tuberculosis
|
–
|
99.98
|
5 of 5
|
PITRM1
|
Alzheimer Disease, Berylliosis
|
–
|
100
|
3 of 3
|
PLA2G6
|
Neuroaxonal Dystrophy, Neurodegeneration With Brain Iron Accumulation, Parkinson Disease
|
AR
|
99.94
|
190 of 191
|
PLAA
|
Neurodevelopmental Disorder, Microcephaly, Spasticity
|
AR
|
99.41
|
6 of 6
|
PLCB1
|
Epileptic Encephalopathy, West Syndrome
|
AR
|
99.92
|
4 of 6
|
PLP1
|
Pelizaeus- Merzbacher Disease, Spastic Paraplegia
|
X,XR,G
|
100
|
–
|
PLPBP
|
Epilepsy
|
AR
|
100
|
–
|
PMM2
|
CongenitalDisorder Of Glycosylation
|
AR
|
100
|
127 of 129
|
PMPCB
|
MultipleMitochondrial DysfunctionsSyndrome
|
AR
|
99.46
|
5 of 5
|
PNKD
|
Paroxysmal Nonkinesigenic Dyskinesia
|
AD
|
99.98
|
6 of 6
|
PNKP
|
Ataxia-Oculomotor Apraxia, Charcot- Marie-Tooth Disease, Epileptic Encephalopathy
|
AR
|
100
|
36 of 36
|
PNPO
|
Pyridoxamine 5-Prime- Phosphate Oxidase Deficiency, Pyridoxal Phosphate- Responsive Seizures
|
AR
|
99.99
|
31 of 31
|
POLG
|
MitochondrialDna DepletionSyndrome, External Ophthalmoplegia WithMitochondrial DnaDeletions, SensoryAtaxic Neuropathy, Dysarthria, Ophthalmoparesis, Alpers-Huttenlocher Syndrome, Mitochondrial Neurogastrointestinal Encephalomyopathy
|
AD,AR
|
99.92
|
325 of 326
|
POLR3A
|
Leukodystrophy, Progeroid Syndrome, Tremor-Ataxia-Central Hypomyelination Syndrome, Wiedemann- Rautenstrauch Syndrome
|
AR
|
100
|
122 of 122
|
POLR3B
|
Leukodystrophy, Hypomyelination- Hypogonadotropic Hypogonadism- Hypodontia Syndrome
|
AR
|
100
|
61 of 61
|
POMGNT1
|
Muscular Dystrophy- Dystroglycanopathy, Retinitis Pigmentosa, Muscle-Eye-Brain Disease, Walker- Warburg Syndrome
|
AR
|
99.91
|
82 of 83
|
POMT1
|
Limb-Girdle Muscular Dystrophy- Dystroglycanopathy, Muscle-Eye-Brain Disease, Walker- Warburg Syndrome
|
AR
|
100
|
105 of 105
|
POMT2
|
Limb-Girdle Muscular Dystrophy- Dystroglycanopathy, Muscle-Eye-Brain Disease, Walker- Warburg Syndrome
|
AR
|
|
74 of 74
|
PPP2CA
|
Neurodevelopmental Disorder And Language Delay
|
AD
|
99.9
|
14 of 14
|
PPP3CA
|
Arthrogryposis, Cleft Palate, Craniosynostosis, Impaired Intellectual Development, Epileptic Encephalopathy
|
AD
|
99.98
|
16 of 16
|
PPT1
|
Ceroid Lipofuscinosis
|
AR
|
100
|
81 of 81
|
PQBP1
|
Renpenning Syndrome, Hamel Cerebro -Palato-Cardiac Syndrome
|
X,XR,G
|
99.99
|
–
|
PRDM8
|
Epilepsy, LaforaBody Disease
|
AR
|
89.24
|
1 of 1
|
PRICKLE1
|
Epilepsy, Unverricht- LundborgDisease
|
AR
|
98.41
|
23 of 23
|
PRICKLE2
|
Epilepsy
|
–
|
94.92
|
6 of 6
|
PRIMA1
|
MiocardialInfarction, Ichthyosis
|
–
|
99.59
|
1 of 1
|
PRODH
|
Hyperprolinemia, Schizophrenia
|
AD,AR
|
98.57
|
5 of 5
|
PRRT2
|
Convulsions, Dyskinesia, Epilepsy, Hemiplegic Migraine
|
AD
|
99.93
|
111 of 111
|
PSAP
|
Saposin Deficiency, Gaucher Disease, Krabbe Disease, Metachromatic Leukodystrophy, Encephalopathy
|
AR
|
100
|
33 of 33
|
PTCH1
|
Basal Cell Carcinoma, Basal Cell Nevus Syndrome, Holoprosencephaly, Gorlin Syndrome, Monosomy 9q22.3
|
AD
|
98.89
|
498 of 502
|
PTEN
|
Cowden Disease, Autism, Meningioma, Bannayan-Riley- Ruvalcaba Syndrome, Juvenile Polyposis Of Infancy, Lhermitte- Duclos Disease, Proteus Syndrome, Segmental Outgrowth- Lipomatosis- Arteriovenous Malformation- Epidermal Nevus Syndrome
|
AD
|
99.97
|
609 of 629
|
PTPN11
|
Myelomonocytic Leukemia, LeopardSyndrome, Metachondromatosis NoonanSyndrome
|
AD
|
100
|
150 of 151
|
PTPN23
|
Neurodevelopmental Disorder And Structural Brain Anomalies
|
AR
|
99.99
|
17 of 17
|
PTS
|
6-Pyruvoyl- Tetrahydropterin SynthaseDeficiency
|
AR
|
99.97
|
108 of 112
|
PUM1
|
Spinocerebellar Ataxia
|
AD
|
99.98
|
8 of 8
|
PURA
|
Mental Retardation
|
AD
|
85.36
|
59 of 65
|
PYCR2
|
Leukodystrophy, Leukoence phalopathy
|
AR
|
98.29
|
14 of 14
|
QARS
|
Microcephaly
|
–
|
100
|
12 of 12
|
QDPR
|
Phenylketonuria, Dihydropteridine Reductase Deficiency
|
AR
|
100
|
66 of 67
|
RAB39B
|
Mental Retardation, Parkinsonism
|
X,XR,G
|
100
|
–
|
RAB3GAP1
|
Warburg Micro Syndrome, Cataract- Intellectual Disability- Hypogonadism Syndrome
|
AR
|
99.94
|
70 of 70
|
RAI1
|
Smith-Magenis Syndrome, 17p11.2 Microduplication Syndrome, Gene Duplication Syndrome
|
AD
|
99.91
|
50 of 53
|
RALA
|
Tuberculosos, MyocardialInfarction
|
–
|
99.94
|
7 of 7
|
RANBP2
|
Necrotizing Encephalopathy
|
AD
|
99.41
|
9 of 9
|
RARS1
|
Leukodystrophy
|
AR
|
99.64
|
28 of 28
|
RARS2
|
Pontocerebellar Hypoplasia
|
AR
|
99.98
|
39 of 40
|
RBFOX1
|
Epilepsy, Spinocerebellar Ataxia, Developmental Coordination Disorder
|
–
|
97.99
|
4 of 5
|
RBFOX3
|
Epilepsy, EctodermalDysplasia
|
–
|
88.9
|
1 of 1
|
RELN
|
Epilepsy, Lissencephaly
|
AD,AR
|
100
|
70 of 70
|
RFT1
|
CongenitalDisorder Of Glycosylation
|
AR
|
99.98
|
18 of 18
|
RHOBTB2
|
Epileptic Encephalopathy
|
AD
|
100
|
6 of 6
|
RMND1
|
CombinedOxidative Phosphorylation Deficiency
|
AR
|
99.67
|
15 of 16
|
RNASEH2A
|
Aicardi-Goutieres Syndrome
|
AR
|
100
|
23 of 23
|
RNASEH2B
|
Aicardi-Goutieres Syndrome
|
AR
|
99.95
|
41 of 41
|
RNASEH2C
|
Aicardi-Goutieres Syndrome
|
AR
|
100
|
14 of 14
|
RNASET2
|
Leukoencephalopathy
|
AR
|
100
|
11 of 13
|
RNF13
|
Epileptic Encephalopathy
|
AD
|
99.88
|
2 of 2
|
RNF216
|
Cerebellar Ataxia- Hypogonadism Syndrome
|
AR
|
99.89
|
15 of 15
|
RNR1
|
MERRF (Myoclonus Epilepsy Associated With Ragged-Red Fibres)
|
–
|
–
|
–
|
ROGDI
|
Kohlschutter-Tonz Syndrome, Amelocere brohypohidrotic Syndrome
|
AR
|
99.83
|
10 of 12
|
RORA
|
Intellectual Developmental Disorder, Epilepsy, Cerebellar Ataxia
|
AD
|
99.94
|
12 of 12
|
RORB
|
Epilepsy
|
AD
|
99.98
|
4 of 4
|
RPGRIP1L
|
Coach Syndrome, Joubert Syndrome, Meckel Syndrome, Joubert Syndrome
|
AR
|
99.96
|
52 of 52
|
RUBCN
|
Spinocerebellar And Cerebellar Ataxia
|
AR
|
99.96
|
–
|
RYR3
|
Deafness
|
–
|
99.98
|
20 of 20
|
SAMD12
|
Epilepsy
|
AD
|
99.74
|
–
|
SAMHD1
|
Aicardi-Goutieres Syndrome
|
AD,AR
|
100
|
51 of 51
|
SATB2
|
Chromosome 2q32- Q33 Deletion Syndrome
|
AD
|
99.87
|
97 of 124
|
SCARB2
|
Action Myoclonus- Renal Failure Syndrome, Gaucher Disease, Unverricht-Lundborg Disease
|
AR
|
99.95
|
29 of 29
|
SCN10A
|
Episodic Pain Syndrome, Brugada Syndrome, Paroxysmal Extreme Pain Disorder, Primary Erythromelalgia, Romano-Ward Syndrome
|
AD
|
99.89
|
96 of 96
|
SCN1A
|
Epileptic Encephalopathy, Febrile Convulsions, Migraine, Dravet Syndrome, Lennox-Gastaut Syndrome
|
AD
|
99.8
|
1776 of 1797
|
SCN1B
|
Atrial Fibrillation, Brugada Syndrome, Epileptic Encephalopathy, Dravet Syndrome, Familial Progressive Cardiac Conduction Defect
|
AD,AR
|
99.67
|
46 of 48
|
SCN2A
|
Epileptic Encephalopathy, Episodic Ataxia, Seizures , Dravet Syndrome, West Syndrome
|
AD
|
100
|
351 of 351
|
SCN3A
|
Epileptic Encephalopathy
|
AD
|
99.98
|
18 of 18
|
SCN4A
|
Hyperkalemic Periodic Paralysis, Myasthenic Syndrome, Myotonia, Paramyotonia Congenita Of Von Eulenburg, Postsynaptic Congenital Myasthenic Syndromes
|
AD,AR
|
99.77
|
136 of 142
|
SCN5A
|
Atrial Fibrillation, Brugada Syndrome, Cardiomyopathy, Long Qt Syndrome, Heart Block, Sick Sinus Syndrome, Sudden Infant Death Syndrome, Romano-Ward Syndrome
|
AD,AR,MU
|
99.45
|
929 of 942
|
SCN8A
|
Cognitive Impairment With Or Without Cerebellar Ataxia, Epileptic Encephalopathy, Myoclonus, Seizures, Infantile Convulsions And Choreoathetosis
|
AD
|
97.85
|
156 of 172
|
SCN9A
|
Erythermalgia, Epilepsy, Indifference To Pain, Neuropathy, Extreme Pain Disorder, Dravet Syndrome, Primary Erythromelalgia
|
AD,AR
|
96.25
|
126 of 137
|
SCO1
|
ComplexIv Deficiency
|
AR,MI
|
100
|
6 of 6
|
SCO2
|
Cardioence phalomyopathy, Myopia, Charcot-Marie- Tooth Disease, Leigh Syndrome With Cardiomyopathy
|
AD,AR
|
100
|
38 of 38
|
SDHA
|
Cardiomyopathy, Leigh Syndrome, Paragangliomas, Pheochromocytoma- Paraganglioma, Succinate-Coq Reductase Deficiency
|
AD,AR,MI
|
99.98
|
103 of 103
|
SDHAF1
|
Succinate-Coq Reductase Deficiency
|
AR
|
100
|
6 of 6
|
SERAC1
|
Methylglutaconic Aciduria, Deafness, Encephalopathy, Leigh-Like Syndrome
|
AR
|
99.93
|
53 of 53
|
SERPINI1
|
Encephalopathy
|
AD
|
100
|
9 of 9
|
SETBP1
|
Mental Retardation, Schinzel-Giedion Midface-Retraction Syndrome, Intellectual Disability-Expressive Aphasia-Facial Dysmorphism Syndrome
|
AD
|
98.61
|
43 of 43
|
SETD2
|
Luscan-Lumish Syndrome, Sotos Syndrome
|
AD
|
99.83
|
19 of 19
|
SGCE
|
MyoclonicDystonia
|
AD
|
99.46
|
94 of 98
|
SGSH
|
Mucopolysaccharidosis
|
AR
|
97.7
|
151 of 151
|
SHH
|
Holoprosencephaly, Microphthalmia, Schizencephaly, HypoplasticTibiae- PostaxialPolydactyly Syndrome, Radial Hemimelia, Syndactyly
|
AD
|
99.48
|
161 of 184
|
SHOC2
|
NoonanSyndrome
|
AD
|
99.98
|
8 of 8
|
SIK1
|
Myoclonic And Epileptic Encephalopathy, West Syndrome
|
AD
|
99.67
|
9 of 9
|
SIX3
|
Holoprosencephaly, Schizencephaly
|
AD
|
99.79
|
79 of 80
|
SLC12A5
|
Epileptic Encephalopathy
|
AD,AR
|
100
|
19 of 19
|
SLC13A5
|
EpilepticEnce phalopathy, Amelocerebrohy pohidrotic Syndrome
|
AR
|
95.92
|
24 of 24
|
SLC17A5
|
Infantile Sialic Acid Storage Disorder, Sialuria
|
AR
|
99.91
|
49 of 49
|
SLC19A3
|
Basal Ganglia Disease, Leigh Syndrome, Leukodystrophy
|
AR
|
100
|
38 of 39
|
SLC1A2
|
Epileptic Encephalopathy
|
AD
|
100
|
7 of 7
|
SLC1A3
|
Episodic Ataxia
|
AD
|
100
|
13 of 13
|
SLC1A4
|
SpasticTetraplegia, Microcephaly
|
AR
|
99.76
|
8 of 9
|
SLC25A1
|
D-2- And L-2- Hydroxyglutaric Aciduria, Myasthenic Syndrome
|
AR
|
90
|
23 of 25
|
SLC25A12
|
Epileptic Encephalopathy
|
AR
|
100
|
7 of 7
|
SLC25A15
|
Hyperornithinemia- Hyperammonemia- Homocitrullinuria Syndrome
|
AR
|
100
|
41 of 41
|
SLC25A19
|
Microcephaly, Thiamine Metabolism Dysfunction Syndrome
|
AR
|
97.13
|
10 of 10
|
SLC25A22
|
Epileptic Encephalopathy, Myoclonic Encephalopathy
|
AR
|
100
|
16 of 16
|
SLC25A42
|
Metabolic Crises, Encephalomyopathy
|
AR
|
99.91
|
2 of 2
|
SLC2A1
|
Choreoathetosis, Epilepsy, Glucose Transport Defect, Stomatin-Deficient Cryohydrocytosis
|
AD,AR
|
99.99
|
301 of 304
|
SLC35A1
|
CongenitalDisorder Of Glycosylation
|
AR
|
100
|
6 of 6
|
SLC35A2
|
CongenitalDisorder Of Glycosylation
|
X,XD,G
|
99.97
|
–
|
SLC35A3
|
Arthrogryposis, Autism Spectrum Disorder-Epilepsy- Arthrogryposis Syndrome
|
AR
|
99.94
|
5 of 5
|
SLC35C1
|
CongenitalDisorder Of Glycosylation
|
AR
|
99.73
|
8 of 8
|
SLC39A8
|
CongenitalDisorder Of Glycosylation
|
AR
|
99.89
|
7 of 7
|
SLC46A1
|
FolateMalabsorption
|
AR
|
99.8
|
21 of 21
|
SLC4A10
|
Epilepsy, Corneal Dystrophy
|
–
|
99.94
|
4 of 4
|
SLC6A1
|
Myoclonic- AstasticEpilepsy
|
AD
|
100
|
55 of 55
|
SLC6A5
|
Hyperekplexia
|
AD,AR
|
100
|
37 of 37
|
SLC6A8
|
CreatineDeficiency Syndrome
|
X,XR,G
|
99.87
|
–
|
SLC6A9
|
Glycine Encephalopathy
|
AR
|
99.99
|
5 of 5
|
SLC9A6
|
Christianson Syndrome
|
X,XD,G
|
98.87
|
–
|
SMARCA2
|
Nicolaides-Baraitser Syndrome, Intellectual Disability-Sparse Hair-Brachydactyly Syndrome
|
AD
|
97.99
|
80 of 81
|
SMC1A
|
Cornelia De Lange Syndrome, Semilobar Holoprosencephaly, Wiedemann-Steiner Syndrome
|
X,XR,XD,G
|
100
|
–
|
SMC3
|
Cornelia De Lange Syndrome
|
AD
|
100
|
30 of 30
|
SMS
|
Mental Retardation
|
X,XR,G
|
84.04
|
–
|
SNAP25
|
Myasthenic Syndrome
|
AD
|
100
|
6 of 6
|
SNIP1
|
Psychomotor Retardation, Craniofacial Dysmorphism
|
AR
|
99.68
|
1 of 1
|
SNORD118
|
Leukoencephalopathy
|
AR
|
–
|
–
|
SNX27
|
Epilepsy, Parkinson Disease
|
–
|
99.52
|
1 of 1
|
SOX10
|
Waardenburg Syndrome, KallmannSyndrome
|
AD
|
99.74
|
139 of 147
|
SPATA5
|
Epilepsy, Deafness
|
AR
|
99.83
|
30 of 30
|
SPR
|
Dystonia, Sepiapterin Reductase Deficiency
|
AD,AR
|
99.89
|
27 of 27
|
SPRED1
|
LegiusSyndrome
|
AD
|
100
|
84 of 84
|
SPTAN1
|
Epileptic Encephalopathy, West Syndrome
|
AD
|
100
|
52 of 53
|
SPTBN4
|
Myopathy, Deafness
|
AR
|
99.26
|
10 of 10
|
SRGAP2
|
Epileptic Encephalopathy, Pilocytic Astrocytoma, West Syndrome, Chromosome 3pter-P25 Deletion Syndrome
|
–
|
96.8
|
1 of 1
|
SRPX2
|
Rolandic Epilepsy, Speech Dyspraxia , Bilateral Perisylvian Polymicrogyria
|
AD
|
100
|
–
|
ST3GAL3
|
Epileptic Encephalopathy, Mental Retardation, West Syndrome
|
AR
|
100
|
5 of 5
|
ST3GAL5
|
EpilepsySyndrome
|
AR
|
99.17
|
6 of 6
|
STAG1
|
Mental Retardation, Facial Dysmorphism , Gastroesophageal Reflux
|
AD
|
99.98
|
16 of 22
|
STARD7
|
Epilepsy
|
AD
|
98.13
|
1 of 1
|
STIL
|
Microcephaly
|
AR
|
99.94
|
18 of 18
|
STRADA
|
Polyhydramnios, Megalencephaly, Epilepsy
|
AR
|
97.95
|
4 of 6
|
STX1B
|
GeneralizedEpilepsy, FebrileSeizures
|
AD
|
100
|
24 of 24
|
STXBP1
|
Epileptic Encephalopathy, 9q33.3q34.11 Microdeletion Syndrome, Rett Syndrome, Dravet Syndrome, West Syndrome
|
AD
|
100
|
209 of 215
|
SUMF1
|
Multiple Sulfatase Deficiency
|
AR
|
100
|
52 of 52
|
SUOX
|
Sulfocysteinuria
|
AR
|
99.98
|
28 of 28
|
SURF1
|
Charcot-Marie- Tooth Disease, Leigh Syndrome, Leukodystrophy
|
AR,MI
|
98.59
|
117 of 124
|
SYN1
|
Epilepsy, LearningDisabilities
|
X,XR,XD,G
|
91.7
|
–
|
SYNGAP1
|
Mental Retardation, EpilepticEncephalopathy
|
AD
|
99.46
|
168 of 171
|
SYNJ1
|
EpilepticEncephalopathy, Parkinson Disease
|
AR
|
99.81
|
30 of 32
|
SYP
|
Mental Retardation
|
X,XR,G
|
99.98
|
–
|
SZT2
|
EpilepticEncephalopathy
|
AR
|
99.98
|
39 of 39
|
TACO1
|
Mitochondrial Complex Iv Deficiency, Leigh Syndrome, Leukodystrophy
|
AR,MI
|
100
|
3 of 3
|
TAF1
|
Dystonia, Mental Retardation, Parkinsonism
|
X,XR,G
|
99.74
|
–
|
TBC1D20
|
Warburg Micro Syndrome
|
AR
|
99.94
|
6 of 6
|
TBC1D24
|
Deafness, Doors Syndrome, Epileptic Encephalopathy, Myoclonic Epilepsy, Dystonia
|
AD,AR
|
100
|
80 of 80
|
TBCD
|
Encephalopathy, Diffuse Brain Atrophy, Microcephaly
|
AR
|
94.89
|
28 of 28
|
TBCE
|
Epileptic Encephalopathy, Hypoparathyroidism- Retardation- Dysmorphism Syndrome, Kenny-Caffey Syndrome, Spastic Ataxia, Sanjad- Sakati Syndrome
|
AR
|
100
|
8 of 8
|
TBCK
|
Hypotonia, Intellectual Disability
|
AR
|
99.95
|
15 of 15
|
TBL1XR1
|
Mental Retardation, Pierpont Syndrome, PromyelocyticLeukemia
|
AD
|
99.78
|
23 of 23
|
TBX1
|
Conotruncal Heart Malformations, Digeorge Syndrome , Tetralogy Of Fallot, Velocardiofacial Syndrome, 22q11.2 Deletion Syndrome, 22q11.2 Microduplication Syndrome
|
AD,AR
|
88.7
|
35 of 42
|
TCF4
|
Corneal Dystrophy, Pitt-Hopkins Syndrome, Sclerosing Cholangitis
|
AD
|
98.91
|
124 of 124
|
TDP2
|
Spinocerebellar Ataxia
|
AR
|
99.93
|
8 of 8
|
TIMM50
|
3-Methylglutaconic Aciduria
|
AR
|
91
|
7 of 7
|
TMEM67
|
Bardet-Biedl Syndrome, Coach Syndrome, Joubert Syndrome, Meckel Syndrome, Nephronophthisis, Rhyns Syndrome
|
AR
|
96.93
|
177 of 179
|
TMEM70
|
MitochondrialComplex V Deficiency, Encephalo- Cardiomyopathy
|
AR
|
100
|
22 of 24
|
TNK2
|
Gastric Adenocarcinoma, Epilepsy
|
–
|
99.72
|
6 of 7
|
TPK1
|
ThiamineMetabolism Dysfunction Syndrome
|
AR
|
99.81
|
15 of 15
|
TPP1
|
CeroidLipofuscinosis, Spinocerebellar Ataxia
|
AR
|
100
|
147 of 147
|
TRAK1
|
EpilepticEncephalopathy
|
AR
|
99.28
|
7 of 7
|
TRAPPC6B
|
Neurodevelopmental Disorder, Microcephaly, Epilepsy, Brain Atrophy
|
AR
|
100
|
4 of 4
|
TREX1
|
Aicardi-GoutieresSyndrome, Chilblain Lupus, Systemic Lupus Erythematosus, Vasculopathy, Cerebral Leukodystrophy
|
AD,AR
|
100
|
75 of 75
|
TRIM8
|
EpilepticEncephalopathy
|
–
|
99.5
|
7 of 7
|
TRNF
|
Mitochondrial Myopathy, Epileptic Encephalopathy, MELAS (Myoclonic Encephalopathy, Lactic Acidosis, And Stroke-Like Episodes), MERRF (Myoclonus Epilepsy Associated With Ragged-Red Fibres)
|
MI
|
–
|
–
|
TRNH
|
MELAS (Myoclonic Encephalopathy, Lactic Acidosis, And Stroke-Like Episodes), MERRF (Myoclonus Epilepsy Associated With Ragged-Red Fibres)
|
–
|
–
|
–
|
TRNI
|
MERRF (Myoclonus Epilepsy Associated With Ragged-Red Fibres)
|
MI
|
–
|
–
|
TRNK
|
MELAS (Myoclonic Encephalopathy, Lactic Acidosis, And Stroke-Like Episodes), MERRF (Myoclonus Epilepsy Associated With Ragged-Red Fibres), Leigh Syndrome, Cardiomyopathy, Deafness
|
MI
|
–
|
–
|
TRNL1
|
MELAS (Myoclonic Encephalopathy, Lactic Acidosis, And Stroke-Like Episodes), MERRF (Myoclonus Epilepsy Associated With Ragged-Red Fibres), Kearns- Sayre Syndrome, Deafness, Leigh Syndrome, Ophthalmoplegia
|
MI
|
–
|
–
|
TRNP
|
MERRF (Myoclonus Epilepsy Associated With Ragged-Red Fibres)
|
MI
|
–
|
–
|
TRNQ
|
MELAS (Myoclonic Encephalopathy, Lactic Acidosis, And Stroke-Like Episodes), MERRF (Myoclonus Epilepsy Associated With Ragged- Red Fibres)
|
MI
|
–
|
–
|
TRNS1
|
Mitochondrial Complex Iv Deficiency, MELAS (Myoclonic Encephalopathy, Lactic Acidosis, And Stroke-Like Episodes), MERRF (Myoclonus Epilepsy Associated With Ragged-Red Fibres), Ophthalmoplegia, Palmoplantar Keratoderma- Deafness Syndrome
|
AR,MI
|
–
|
–
|
TRNS2
|
MELAS (Myoclonic Encephalopathy, Lactic Acidosis, And Stroke-Like Episodes), MERRF (Myoclonus Epilepsy Associated With Ragged-Red Fibres), Usher Syndrome
|
MI
|
–
|
–
|
TSC1
|
Dysplasia Of Taylor, Lymphangioleiomyomatosis, Tuberous Sclerosis
|
AD
|
99.86
|
390 of 406
|
TSC2
|
Dysplasia Of Taylor, Lymphangioleiomyomatosis, Tuberous Sclerosis
|
AD
|
100
|
1157 of 1159
|
TSEN2
|
Pontocerebellar Hypoplasia
|
AR
|
95.47
|
4 of 5
|
TSEN34
|
Pontocerebellar Hypoplasia
|
AR
|
100
|
1 of 1
|
TSEN54
|
Encephalopathy, Olivopontocerebellar Hypoplasia
|
AR
|
96.94
|
20 of 22
|
TTC19
|
Mitochondrial ComplexIii Deficiency
|
AR
|
95.3
|
10 of 12
|
TUBA1A
|
Lissencephaly
|
AD
|
100
|
95 of 95
|
TUBA8
|
Polymicrogyria With Optic Nerve Hypoplasia
|
AR
|
80.97
|
5 of 5
|
TUBB2A
|
Cortical Dysplasia
|
AD
|
81.71
|
5 of 7
|
TUBB2B
|
Cortical Dysplasia, Dysequilibrium Syndrome, Polymicrogyria
|
AD
|
84.28
|
29 of 38
|
TUBB4A
|
Dystonia, Leukodystrophy
|
AD
|
89.81
|
44 of 44
|
TWNK
|
Spinocerebellar Ataxia, Perrault Syndrome , Ophthalmoplegia, Dysarthria
|
AD,AR
|
–
|
–
|
UBA5
|
Epileptic Encephalopathy, Spinocerebellar Ataxia
|
AR
|
99.98
|
19 of 19
|
UBE2A
|
Mental Retardation
|
X,XR,G
|
99.99
|
–
|
UBE3A
|
Angelman Syndrome, 15q11q13 Microduplication Syndrome
|
AD
|
99.98
|
208 of 211
|
UNC80
|
Hypotonia, SpeechImpairment
|
AR
|
99.95
|
39 of 39
|
VAMP2
|
Neurodevelopmental Disorder, Hypotonia, Hyperkinetic Movements
|
AD
|
99.62
|
5 of 5
|
VARS1
|
Neurodevelopmental Disorder, Microcephaly, Cortical Atrophy
|
AR
|
97.86
|
19 of 20
|
VPS13A
|
Choreoacanthocytosis
|
AR
|
99.37
|
120 of 122
|
VPS13B
|
Cohen Syndrome
|
AR
|
99.98
|
182 of 190
|
WARS2
|
Neurodevelopmental Disorder, Lactic Acidosis, Oxidative Phosphorylation Defect
|
AR
|
99.95
|
14 of 15
|
WASF1
|
Neurodevelopmental Disorder, Seizures
|
AD
|
97.03
|
3 of 3
|
WDR26
|
Skraban-Deardorff Syndrome, Intellectual Disability, Seizures, Facial Dysmorphism
|
AD
|
99.31
|
22 of 22
|
WDR45
|
Neurodegeneration, Brain Iron Accumulation, West Syndrome
|
X,XD,G
|
100
|
–
|
WWOX
|
Epileptic Encephalopathy, Esophageal Cancer, Spinocerebellar Ataxia, Gonadal Dysgenesis, Squamous Cell Carcinoma Of The Esophagus
|
AR
|
99.94
|
44 of 44
|
YEATS2
|
MyoclonicEpilepsy
|
AD
|
99.98
|
1 of 1
|
YWHAG
|
Epileptic Encephalopathy
|
AD
|
99.94
|
5 of 5
|
ZDHHC9
|
Mental Retardation
|
X,G
|
100
|
–
|
ZEB2
|
Mowat-Wilson Syndrome
|
AD
|
98.95
|
253 of 254
|
ZFYVE26
|
SpasticParaplegia
|
AR
|
99.95
|
48 of 48
|
ZIC2
|
Holoprosencephaly
|
AD
|
84.47
|
86 of 112
|